Shares have cratered since April, when the company slashed its financial guidance and posted earnings that missed ...

UnitedHealth continues to face headwinds due to regulatory scrutiny, Medicare costs, and management changes. Read more on ...

UnitedHealth's management has already signaled an improving outlook for the second half of 2025. Click here to read an ...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses ...

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...

UnitedHealth Group faces challenges with medical billing and profit margins. Wolfe Research lowered the stock price target.

Universal Health Services Inc. Cl B closed 27.26% short of its 52-week high of $243.25, which the company reached on ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

Ten analysts recently shared bullish-to-bearish takes on Elevance Health over the last three months, leaning heavily bullish.